Literature DB >> 12894956

Hypertension, dyslipidemia, body mass index, diabetes and smoking status in Aboriginal Australians in a remote community.

Zhiqiang Wang1, Wendy E Hoy.   

Abstract

OBJECTIVES: Study objectives were: 1) to describe the differences in the prevalence of CHD risk factors between Aboriginal people in a remote community and the general Australian population; and 2) to compare the predicted risks of CHD events between Aboriginal and non-Aboriginal Australians.
DESIGN: A cross-sectional study. PARTICIPANTS: 681 Aboriginal adults aged 25 to 74 years.
RESULTS: Aboriginal young adults had substantially higher prevalence of diabetes compared to non-Aboriginal Australians. The prevalence ratios for diabetes were 12.5, 5.6, 3.2, 1.3, and 0.73 for 25-, 35-, 45-, 55-, and 65- to 74-year-old females, respectively. The corresponding values for males were 12.1, 2.7, 2.9, 0.69, and 0.42. Young females had a higher prevalence of obesity, overweight, and abnormal waist circumference, while males and females 45 years and older tended to have a lower prevalence of overweight and abnormal waist circumference. Compared to the general population, Aboriginal adults had a lower prevalence of abnormal total cholesterol but a higher prevalence of abnormal HDL, triglycerides, hypertension, and smoking. The risk ratios of abnormal total cholesterol for females ages 25-34, 35-44, 45-54, 55-64, and 65-75 years were 0.38, 0.53, 0.48, 0.48, and 0.41, respectively.
CONCLUSIONS: Aboriginal people in the remote community experienced different levels of CHD risk predictors from the general Australian population. They had a lower prevalence of abnormal total cholesterol and a higher prevalence of abnormal HDL, smoking, diabetes, and hypertension.

Entities:  

Mesh:

Year:  2003        PMID: 12894956

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  8 in total

1.  Dietary Adherence, Glycemic Control, and Psychological Factors Associated with Binge Eating Among Indigenous and Non-Indigenous Chileans with Type 2 Diabetes.

Authors:  Sylvia Herbozo; Patricia M Flynn; Serena D Stevens; Hector Betancourt
Journal:  Int J Behav Med       Date:  2015-12

2.  Incidence of type 2 diabetes in Aboriginal Australians: an 11-year prospective cohort study.

Authors:  Zhiqiang Wang; Wendy E Hoy; Damin Si
Journal:  BMC Public Health       Date:  2010-08-17       Impact factor: 3.295

3.  Exploring aboriginal views of health using fuzzy cognitive maps and transitive closure. A case study of the determinants of diabetes.

Authors:  Brian G Giles; G Haas; M Sajna; C S Findlay
Journal:  Can J Public Health       Date:  2008 Sep-Oct

4.  Prediction of cardiovascular disease risk using waist circumference among Aboriginals in a remote Australian community.

Authors:  Odewumi Adegbija; Wendy Hoy; Zhiqiang Wang
Journal:  BMC Public Health       Date:  2015-01-31       Impact factor: 3.295

5.  Predicting absolute risk of type 2 diabetes using age and waist circumference values in an aboriginal Australian community.

Authors:  Odewumi Adegbija; Wendy Hoy; Zhiqiang Wang
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  Health service changes to address diabetes in pregnancy in a complex setting: perspectives of health professionals.

Authors:  R Kirkham; J A Boyle; C Whitbread; M Dowden; C Connors; S Corpus; L McCarthy; J Oats; H D McIntyre; E Moore; K O'Dea; A Brown; L Maple-Brown
Journal:  BMC Health Serv Res       Date:  2017-08-03       Impact factor: 2.655

7.  Urban-rural disparity in the utilization of national community-based hypertension monitoring service-results from the China Health and Retirement Longitudinal Study, 2015.

Authors:  Hongxun Song; Da Feng; Ruoxi Wang; Shangfeng Tang; Bishwajit Ghose; Gang Li; Xiaoyu Chen; Zhanchun Feng
Journal:  PeerJ       Date:  2019-10-15       Impact factor: 2.984

8.  Lifetime risk of developing coronary heart disease in Aboriginal Australians: a cohort study.

Authors:  Zhiqiang Wang; Wendy E Hoy
Journal:  BMJ Open       Date:  2013-01-30       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.